EHA 2023 | EMN 27: Belantamab mafodotin in relapsed or refractory AL Amyloidosis patients
Channel: Myeloma Patients Europe
Date: 11/06/2023

Interview filmed with Dr. Efstathios Kastritis, Associate Professor at the National and Kapodistrian University of Athens, Greece, to summarise the results of the clinical trial EMN 27, presented at European Hematology Association’s annual congress (EHA 2023 Virtual), held in June 2023.